Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients

Liver International

Volumn 29, Issue 7, 2009, Pages 1065-1070

  Abbas, Omaima M ^a   Omar, Nabil A ^b   Zaghla, Hassan E ^b   Faramawi, Mohammad F ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Coinfection; Hepatitis C; Mixed cryoglobulinaemia; S. mansoni

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CRYOGLOBULIN; HELMINTH ANTIBODY; IMMUNOGLOBULIN; SCHISTOSOMA MANSONI IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EGYPT; FEMALE; GENETIC HETEROGENEITY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; RISK FACTOR; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

ADULT; ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES, HELMINTH; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 67650480392     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.01970.x     Document Type: Article

References (43)

1. National Institute of Health Consensus Development Conference Statement. Management of hepatitis C. Gastroenterology 2002; 123: 2082-99.
2. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
3. National Institute of Health Consensus Development Conference Statement. Management of hepatitis C virus. Hepatology 1997; 26(Suppl. 1): 2S-10S.
4. Zignego AL, Ferri C, for the Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV Infection, et al. Extrahepatic manifestations of hepatitis C virus infection: A general overview and guidelines for a clinical approach. Dig Liver Dis 2007; 39: 2-17.
5. Angello V. The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 1995; 42: 197-84.
6. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974; 57: 775-88.
7. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-20.
8. Bach JF. Predictive medicine in autoimmune diseases: From the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol 1994; 72: 156-61.
9. van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: Consequences and mechanisms. Immunobiology 2007; 212: 475-90.
10. Mohamed A, Elsheikh A, Ghandour Z, Al Karawi M. Impact of hepatitis C virus infection on schistosomal liver disease. Hepatogastroenterology 1998; 45: 1492-6.
11. Kamal SM, Graham CS, He Q, et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: Relation to progression of liver fibrosis. J Infect Dis 2004; 189: 1140-50.
12. Kamal S, Madwar M, Bianchi L, et al. Clinical, virological and histopathological features: Long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 2000; 20: 281-9.
13. Ferri C, Antonelli A, Mascia MT, et al. B-cells and mixed cryoglobulinaemia. Autoimmun Rev 2007; 7: 114-20.
14. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinaemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33: 355-74.
15. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: Immune complex relations. Lancet Infect Dis 2005; 5: 227-36.
16. Gad A, Tanaka E, Matsumoto A, et al. Factors predisposing to the occurrence of cryoglobulinaemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: Ethnic and genotypic influence. J Med Virol 2003; 70: 594-9.
17. Loffreda S, Muratori P, Muratori L, et al. Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinaemic patients. J Hepatol 2003; 38: 230-6.
18. Loffreda S, Muratori L, Bianchi FB, Lenzi M. Enhanced PBMC Th1 cytokine production in HCV-infected cryoglobulinaemic patients. J Hepatol 2001; 34(Suppl. 1): 147.
19. Saadoun D, Boyer O, Trébeden-Nègre H, et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinaemia vasculitis. J Hepatol 2004; 41: 1031-7.
20. Boyer O, Saadoun D, Abriol J, et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinaemia vasculitis. Blood 2004; 103: 3428-30.
21. Godkin A, Ng WF, Gallagher K, et al. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: A mechanism to limit collateral damage? J Allergy Clin Immunol 2008; 121: 1277-84.
22. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L. Cryoglobulinaemia vasculitis. Curr Opin Rheumatol 2002; 14: 29-35.
23. Cacoub P, Renou C, Kerr G, et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinaemia. Arthritis Rheum 2001; 44: 2118-24.
24. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
25. Kamradt T, Göggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005; 26: 260-7.
26. Moreels TG, Nieuwendijk RJ, De Man JG, et al. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 2004; 53: 99-107.
27. Zaccone P, Fehérvári Z, Jones FM, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003; 33: 1439-49.
28. Sewell D, Qing Z, Reinke E, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15: 59-69.
29. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-93.
30. Mahnke K, Qian Y, Knop J, Enk AH. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003; 101: 4862-9.
31. Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172: 2016-20.
32. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-9.
33. Dammacco F, Sansonno D, Piccoli C, et al. The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinaemia, and overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-57.
34. Sansonno D, Lauletta G, Montrone M, et al. Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol 2005; 143: 288-96.
35. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, et al. Chronic hepatitis C virus infection: Prevalence of extrahepatic manifestations and association with cryoglobulinaemia in Bulgarian patients. World J Gastroenterol 2007; 13: 6518-28.
36. Zignego AL, Giannini C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: An overview. World J Gastroenterol 2007; 13: 2467-78.
37. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinaemia - a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-56.
38. Saadoun D, Asselah T, Resche-Rigon M, et al. Cryoglobulinaemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006; 43: 1337-45.
39. Agnello V. The etiology and pathophysiology of mixed cryoglobulinaemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19: 111-29.
40. Ferri C, Monti M, La Civita L, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinaemia. Blood 1993; 82: 3701-4.
41. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinaemia, and cirrhosis: A meta-analysis. Hepatology 2002; 36(Part 1): 978-85.
42. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinaemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300.
43. Angello V, Elfahal M. Cryoglobulin types and rheumatoid factors associated with clinical manifestations in patients with hepatitis C virus infection. Dig Liver Dis 2007; 39(Suppl. 1): S25-31.